Analyst Activity – B. Riley Initiates Coverage On Regulus Therapeutics (NASDAQ:RGLS) (NASDAQ:RGLS) With a Neutral

ME Staff
-
0

Analyst Ratings For Regulus Therapeutics (NASDAQ:RGLS) (NASDAQ:RGLS)

Today, B. Riley initiated coverage on Regulus Therapeutics (NASDAQ:RGLS) (NASDAQ:RGLS) with a Neutral with a price target of $1.00.

Some recent analyst ratings include

  • 3/28/2018-B. Riley initiated coverage with a Neutral rating.
  • 1/16/2018-Chardan Capital Reiterated Rating of Neutral.
  • 1/5/2018-Leerink Swann initiated coverage with a Outperform rating.
  • 12/11/2017-Wedbush Reiterated Rating of Outperform.
  • 11/14/2017-Needham & Company LLC Reiterated Rating of Hold.
  • 3/3/2017-Cowen Reiterated Rating of Hold.

Recent Insider Trading Activity For Regulus Therapeutics (NASDAQ:RGLS) (NASDAQ:RGLS)
Regulus Therapeutics (NASDAQ:RGLS) (NASDAQ:RGLS) has insider ownership of 4.80% and institutional ownership of 53.72%.

  • On 7/25/2017 Daniel R Chevallard, CFO, bought 54,945 with an average share price of $0.91 per share and the total transaction amounting to $49,999.95.
  • On 7/25/2017 Joseph P Hagan, Insider, bought 219,780 with an average share price of $0.91 per share and the total transaction amounting to $199,999.80.
  • On 7/25/2017 William H Rastetter, Director, bought 274,725 with an average share price of $0.91 per share and the total transaction amounting to $249,999.75.
  • On 3/22/2017 Stelios Papadopoulos, Director, bought 500,000 with an average share price of $1.22 per share and the total transaction amounting to $610,000.00.
  • On 3/7/2017 William H Rastetter, Director, bought 250,000 with an average share price of $1.15 per share and the total transaction amounting to $287,500.00.
  • On 3/3/2016 Joseph P Hagan, COO, bought 10,000 with an average share price of $7.19 per share and the total transaction amounting to $71,900.00.
  • On 2/23/2016 Alnylam Pharmaceuticals, Inc., Major Shareholder, sold 1,000,000 with an average share price of $7.18 per share and the total transaction amounting to $7,180,000.00.

Recent Trading Activity for Regulus Therapeutics (NASDAQ:RGLS) (NASDAQ:RGLS)
Shares of Regulus Therapeutics (NASDAQ:RGLS) closed the previous trading session at 0.79 down -0.01 1.23% with 0.7929999828338623 shares trading hands.